Digital Content 
NEWS #PharmaBuzz
28 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/28/3122322/0/en/CervoMed-Announces-32-Week-Data-from-RewinD-LB-Trial-Extension-Phase-Showing-Neflamapimod-s-Sustained-Effect-on-Slowing-Clinical-Progression-in-Patients-with-Dementia-with-Lewy-Bod.html
08 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/08/3111598/0/en/CervoMed-Announces-Late-Breaking-Presentations-at-Alzheimer-s-Association-International-Congress-2025.html
10 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/10/3096571/0/en/CervoMed-Announces-New-Hire-to-Support-Neflamapimod-Development-and-Commercialization.html
02 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/02/3054108/0/en/Investigators-to-Present-Clinical-Trial-Results-Showing-Neflamapimod-Slows-Clinical-Progression-in-Dementia-with-Lewy-Bodies-in-Oral-Presentation-at-AD-PD-2025.html
17 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/17/3043647/0/en/CervoMed-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Corporate-Updates.html
31 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/31/3018769/0/en/CervoMed-Provides-Update-on-Neflamapimod-DLB-Program-as-Part-of-Presentation-at-the-8th-International-Lewy-Body-Dementia-Conference.html
Share 